CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-08 | HEDRICK MARC H Chief Executive Officer | Purchase | +12,255 | $2.04 | $25K | 12,425 |
| 2024-05-08 | HEDRICK MARC H Chief Executive Officer | Grant or award · Warrants (Right to buy) | +24,510 | 24,510 | ||
| 2024-05-08 | Petersen Greg Director | Purchase | +12,255 | $2.04 | $25K | 36,421 |
| 2024-05-08 | Petersen Greg Director | Grant or award · Warrants (Right to buy) | +24,510 | 24,510 | ||
| 2024-05-08 | Hawkins Richard J Director | Purchase | +4,902 | $2.04 | $10K | 4,903 |
| 2024-05-08 | Hawkins Richard J Director | Grant or award · Warrants (Right to buy) | +9,804 | 9,804 | ||
| 2024-05-08 | Clowes Howard Director | Purchase | +9,804 | $2.04 | $20K | 21,497 |
| 2024-05-08 | Clowes Howard Director | Grant or award · Warrants (Right to buy) | +19,608 | 19,608 | ||
| 2024-05-08 | Lenk Robert P Director | Purchase | +4,167 | $2.04 | $9K | 29,327 |
| 2024-05-08 | Lenk Robert P Director | Grant or award · Warrants (Right to buy) | +8,334 | 8,334 | ||
| 2024-02-22 | Clowes Howard Director | Grant or award · Stock Option (Right to Buy) | +2,250 | 2,250 | ||
| 2024-02-22 | LaFrance Norman D. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +24,073 | 24,073 | ||
| 2024-02-22 | HEDRICK MARC H Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +94,012 | 94,012 | ||
| 2024-02-22 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +18,933 | 18,933 | ||
| 2024-02-22 | Lenk Robert P Director | Grant or award · Stock Option (Right to Buy) | +2,250 | 2,250 | ||
| 2024-02-22 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +2,250 | 2,250 | ||
| 2024-02-22 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +2,250 | 2,250 | ||
| 2024-02-22 | Petersen Greg Director | Grant or award · Stock Option (Right to Buy) | +2,250 | 2,250 | ||
| 2023-11-20 | HEDRICK MARC H Chief Executive Officer | Sale | −2,068 | $1.96 | $4K | 170 |
| 2023-11-16 | Lenk Robert P Director | Purchase | +1,000 | $1.95 | $2K | 25,160 |
Page 7 of 53 · 1,048 trades